| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Tissue Regenix appoints Daniel Lee as CEO
StockMarketWire.com
|
Regenerative medical devices company Tissue Regenix said it had appointed Daniel Lee as chief executive.
Lee was currently the head of the company's US operations, a role he'd commenced in January 2019.
Previous to that, he was CEO of Scaffold Biologics and Aperion Biologics.
At 8:50am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 0.41p
Story provided by StockMarketWire.com
|
|
|
|
|
|
